1. European Urology Oncology
Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma 
Charlotte S. Voskuilen, Donald Schweitzer, Jørgen Bjerggaard Jensen, Anna M. Nielsen, Steven Joniau, Tim Muilwijk, Andrea Necchi, Mounsif Azizi, Philippe E. Spiess, Alberto Briganti, Marco Bandini, Karolien Goffin, Kirsten Bouchelouche, Erik van Werkhoven, Shahrokh F. Shariat, Evanguelos Xylinas, Nessn H. Azawi, Ja Hyeon Ku, Beat Foerster, Bas W.G. van Rhijn, Erik Vegt, Kees Hendricksen 
European Urology Oncology 
DOI: /j.euo
Copyright © 2019 European Association of Urology Terms and Conditions

2. Fig. 1
Kaplan-Meier plots of (A) overall survival (B) cancer-specific survival, and (C) recurrence-free survival for FDG-PET/CT–negative (n=93) and FDG-PET/CT–positive (n=24) patients. FDG-PET/CT = 18F-fluorodeoxyglucose positron emission tomography with computed tomography.
European Urology Oncology DOI: ( /j.euo )
Copyright © 2019 European Association of Urology Terms and Conditions